Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Researchers analyzed more than 350 studies to estimate the prevalence of hepatitis B among people with HIV around the world.
The LIVER Act would increase funding for liver cancer and hepatitis B research and prevention.
Researchers have called for revised treatment guidelines to address the higher risk of fracture in the HIV population.
A recent study of more than 1,000 veterans found that nearly 1% had hepatitis B and 14% had been exposed to the virus.
The 2019 Liver Meeting in Boston provided an array of important findings about the treatment and prevention of chronic liver diseases.
People who receive chemotherapy for cancer have a higher risk of hep B reactivation.
Lonafarnib and bulevirtide, when used with pegylated interferon, reduced hepatitis delta levels in two studies.
Experts are not certain what this latest trend signifies for the trajectory of the opioid use disorder epidemic, however.
Normalizing ALT liver enzyme levels is associated with positive long-term outcomes.
Health officials with Goshen Hospital in Indiana called the risk of infection “extremely low.”
Judge’s ruling may pave the way for opening the nation’s first supervised overdose prevention facility.
Hepatitis B and C, non-alcoholic steatohepatitis (NASH) and alcohol-related liver disease are the main causes of liver cancer and cirrhosis.
New cases of all three viruses have declined in the city over the past decade.
Ask Hep explains why people who are starting treatment for hepatitis C, should be tested for hepatitis B.
Women with a history of the malignancy also survive longer than men after receiving a liver transplant.
In a Phase II study, the drug was safe and well tolerated, and a small number of people achieved benchmarks of success against the virus.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.